Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
47 studies found for:    " September 23, 2009":" October 23, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
Conditions: Malaria;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Zidovudine;   Drug: Lamivudine
22 Active, not recruiting Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons
Conditions: Influenza;   HIV Infections
Intervention:
23 Completed
Has Results
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
Conditions: HIV Infections;   Heart Disease
Interventions: Drug: Lovaza;   Drug: Placebo
24 Completed Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya
Conditions: Unintended Pregnancy;   HIV Infections
Intervention: Procedure: Integrated family planning/HIV care and treatment services
25 Completed Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
Condition: HIV Infections
Interventions: Drug: Darunavir/ritonavir;   Drug: Lopinavir/ritonavir
26 Completed Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV
Condition: HIV Infections
Intervention: Drug: Raltegravir
27 Completed Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana
Condition: HIV Infections
Intervention: Other: Cell phone text message
28 Completed TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: TMC278; Omeprazole
29 Completed Pharmacokinetics of Lamivudine at Two Different Doses
Condition: HIV Infections
Intervention: Drug: Lamivudine (3TC)
30 Unknown  ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
31 Terminated
Has Results
Effect of Rosuvastatin on Endothelial Function
Conditions: HIV Infections;   Cardiovascular Disease
Intervention: Drug: rosuvastatin
32 Terminated
Has Results
Artery Elasticity After Switch From Epzicom to Truvada
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil
33 Completed
Has Results
Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
Conditions: HIV Infection;   Hepatitis C Infection
Interventions: Drug: Nitazoxanide (NTZ);   Drug: Pegylated interferon alfa-2a (PEG);   Drug: Ribavirin (RBV)
34 Completed Mothers Living With HIV and Their Adolescent Children
Conditions: Family Relations;   Mental Health;   Physical Health;   Risky Sexual Behavior;   Substance Use;   HIV Infections
Intervention: Behavioral: Cognitive-behavioral, small-group format sessions
35 Completed Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
Condition: HIV Seropositive
Interventions: Drug: Rocaltrol;   Drug: Vitamin D;   Drug: Calcium
36 Completed
Has Results
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
Conditions: HIV Infections;   Dyslipidemia;   Endothelial Dysfunction
Intervention: Drug: extended release niacin
37 Completed
Has Results
A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: MK0518 (Raltegravir);   Drug: famotidine;   Drug: omeprazole
38 Completed
Has Results
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
39 Completed Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers
Conditions: Tuberculosis;   HIV
Interventions: Drug: Efavirenz (EFV);   Drug: TMC207
40 Active, not recruiting Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Atazanavir/Ritonavir;   Drug: Tenofovir/Emtricitabine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Indicates status has not been verified in more than two years